Related Experiment Videos
Are allogeneic blood transfusions acceptable in elective surgery in colorectal carcinoma?
R L Marquet1, O R Busch, J Jeekel
1Department of Surgery, Erasmus University, Rotterdam, The Netherlands.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Impact of R0/R1 Margin Status on Overall Survival in Node-Positive Resected Pancreatic Ductal Adenocarcinoma: Meta-Analysis.
Annals of surgical oncology·2026
The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Prediction of Isolated Local Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Study.
Annals of surgical oncology·2024
Implementation and outcome of minimally invasive pancreatoduodenectomy in Europe: a registry-based retrospective study - a critical appraisal of the first 3 years of the E-MIPS registry.
International journal of surgery (London, England)·2024
Decluttering chemotherapy agents for HER2+early breast cancer: Do we still need carboplatin?
European journal of cancer (Oxford, England : 1990)·2026
Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.
European journal of cancer (Oxford, England : 1990)·2026
Diagnostic pitfalls and unmet needs in neuroendocrine neoplasms: The added value of collegial expert pathology review through the national TENpath network.
European journal of cancer (Oxford, England : 1990)·2026
Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.
European journal of cancer (Oxford, England : 1990)·2026
Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.
European journal of cancer (Oxford, England : 1990)·2026
Development of an age specific EORTC questionnaire to assess the health-related quality of life (HRQOL) of children with cancer aged 8-14 years - a mixed-methods content elicitation phase I & II EORTC QLG study.
European journal of cancer (Oxford, England : 1990)·2026
Follicular lymphoma and the microenvironment: potential targets and biomarkers.
Expert review of clinical immunology·2026
Targeting the HEC1-NEK2 Axis Suppresses DLBCL Progression and Overcomes Vincristine Resistance.
Molecular cancer therapeutics·2026
Bufalin Inhibits Melanoma Progression and Endothelial Angiogenic Phenotypes via AKT Signaling.
Cancer reports (Hoboken, N.J.)·2026